Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.
Galsky MD, Daneshmand S, Izadmehr S, Gonzalez-Kozlova E, Chan KG, Lewis S, Achkar BE, Dorff TB, Cetnar JP, Neil BO, D'Souza A, Mamtani R, Kyriakopoulos C, Jun T, Gogerly-Moragoda M, Brody R, Xie H, Nie K, Kelly G, Horowitz A, Kinoshita Y, Ellis E, Nose Y, Ioannou G, Cabal R, Del Valle DM, Haines GK, Wang L, Mouw KW, Samstein RM, Mehrazin R, Bhardwaj N, Yu M, Zhao Q, Kim-Schulze S, Sebra R, Zhu J, Gnjatic S, Sfakianos J, Pal SK. Galsky MD, et al. Among authors: gnjatic s. Nat Med. 2024 Apr;30(4):1211. doi: 10.1038/s41591-024-02814-0. Nat Med. 2024. PMID: 38242983 Free PMC article. No abstract available.
Toll-like receptor agonists: are they good adjuvants?
Gnjatic S, Sawhney NB, Bhardwaj N. Gnjatic S, et al. Cancer J. 2010 Jul-Aug;16(4):382-91. doi: 10.1097/PPO.0b013e3181eaca65. Cancer J. 2010. PMID: 20693851 Free PMC article. Review.
Antigen depots: T cell traps?
Gnjatic S, Bhardwaj N. Gnjatic S, et al. Nat Med. 2013 Apr;19(4):397-8. doi: 10.1038/nm.3113. Nat Med. 2013. PMID: 23558621 No abstract available.
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes.
Galsky MD, Wang H, Hahn NM, Twardowski P, Pal SK, Albany C, Fleming MT, Starodub A, Hauke RJ, Yu M, Zhao Q, Sonpavde G, Donovan MJ, Patel VG, Sfakianos JP, Domingo-Domenech J, Oh WK, Akers N, Losic B, Gnjatic S, Schadt EE, Chen R, Kim-Schulze S, Bhardwaj N, Uzilov AV. Galsky MD, et al. Among authors: gnjatic s. Eur Urol. 2018 May;73(5):751-759. doi: 10.1016/j.eururo.2017.12.001. Epub 2017 Dec 13. Eur Urol. 2018. PMID: 29248319 Clinical Trial.
Radiotherapy induces responses of lung cancer to CTLA-4 blockade.
Formenti SC, Rudqvist NP, Golden E, Cooper B, Wennerberg E, Lhuillier C, Vanpouille-Box C, Friedman K, Ferrari de Andrade L, Wucherpfennig KW, Heguy A, Imai N, Gnjatic S, Emerson RO, Zhou XK, Zhang T, Chachoua A, Demaria S. Formenti SC, et al. Among authors: gnjatic s. Nat Med. 2018 Dec;24(12):1845-1851. doi: 10.1038/s41591-018-0232-2. Epub 2018 Nov 5. Nat Med. 2018. PMID: 30397353 Free PMC article. Clinical Trial.
Single-cell immune landscape of human atherosclerotic plaques.
Fernandez DM, Rahman AH, Fernandez NF, Chudnovskiy A, Amir ED, Amadori L, Khan NS, Wong CK, Shamailova R, Hill CA, Wang Z, Remark R, Li JR, Pina C, Faries C, Awad AJ, Moss N, Bjorkegren JLM, Kim-Schulze S, Gnjatic S, Ma'ayan A, Mocco J, Faries P, Merad M, Giannarelli C. Fernandez DM, et al. Among authors: gnjatic s. Nat Med. 2019 Oct;25(10):1576-1588. doi: 10.1038/s41591-019-0590-4. Epub 2019 Oct 7. Nat Med. 2019. PMID: 31591603 Free PMC article.
Tumoral and immune heterogeneity in an anti-PD-1-responsive glioblastoma: a case study.
Restrepo P, Yong R, Laface I, Tsankova N, Nael K, Akturk G, Sebra R, Gnjatic S, Hormigo A, Losic B. Restrepo P, et al. Among authors: gnjatic s. Cold Spring Harb Mol Case Stud. 2020 Apr 1;6(2):a004762. doi: 10.1101/mcs.a004762. Print 2020 Apr. Cold Spring Harb Mol Case Stud. 2020. PMID: 31907277 Free PMC article.
252 results